Aller au contenu principal
Profil bibliographique

Benjamin E. Lee

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

14Publications signalées
712Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Lung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsRadiomics and Machine Learning in Medical ImagingMyasthenia Gravis and Thymoma

Les publications récentes

Accès ouvert 2026 conference-abstract OpenAlex

Randomized multicenter phase II trial of radioimmunotherapy versus chemoimmunotherapy followed by surgery for c-stage IB-III NSCLC (RICHIS trial).

Jonathan Villena-Vargas, Jeffrey L. Port, Dan Jones, Oliver S. Chow et autres

TPS8132 Background: Chemotherapy combined with PD-1 or PD-L1 blockade (chemo-immunotherapy, ChemoIO), administered in the neoadjuvant, adjuvant, or perioperative setting, has become standard of care for surgically resectable non-small cell lung cancer (NSCLC). However, ChemoIO may be associated with significant toxicity that may …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2024 article OpenAlex

A robotic-assisted thymectomy is equivalent to a transsternal resection in large thymomas

Shaikha Nasser Al-Thani, Mohamed Rahouma, Jonathan Villena‐Vargas, Oliver S. Chow et autres

Background: Robotic-assisted thoracoscopic surgery (RATS) is widely accepted for small-to-moderate-size thymomas. However, limited data exists comparing the feasibility of RATS for large tumors ≥5 cm. The aim of this study is to compare the oncological and perioperative outcomes of open thymectomy (OT) …

us (code pays fourni par la source)

6 citations Journal of Thoracic Disease
Accès ouvert 2024 erratum OpenAlex

Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial

Nasser Khaled Altorki, Zachary H. Walsh, Johannes C. Melms, Jeffery L. Port et autres

In this article, the author name Silvia C. Formenti was incorrectly written as Sylvia C. Formenti. The original article has been corrected.

us, il (code pays fourni par la source)

0 citations Nature Communications
Accès ouvert 2023 article OpenAlex

Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial

Nasser Khaled Altorki, Zachary H. Walsh, Johannes C. Melms, Jeffery L. Port et autres

We previously reported the results of a randomized phase II trial (NCT02904954) in patients with early-stage non-small cell lung cancer (NSCLC) who were treated with either two preoperative cycles of the anti-PD-L1 antibody durvalumab alone or combined with immunomodulatory doses of stereotactic …

us, il (code pays fourni par la source)

44 citations Nature Communications
Accès ouvert 2023 article OpenAlex

Sub-Lobar Resection: The New Standard of Care for Early-Stage Lung Cancer

Benjamin E. Lee, Nasser Khaled Altorki

The Lung Cancer Study Group previously established lobectomy as the standard of care for treatment of clinical T1N0 NSCLC. Advances in imaging technology and refinements in staging have prompted a re-investigation to determine the non-inferiority of sub-lobar resections to lobectomies. Two recent …

us (code pays fourni par la source)

17 citations Cancers

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.